Negative p53/Positive p21 Immunostaining Is a Predictor of Favorable Response to Chemotherapy in Patients with Locally Advanced Bladder Cancer

The relationship between clinical response to DNA‐damaging drugs and p53 and p21 status in patients with locally advanced transitional cell carcinoma (TCC) of the bladder was assessed. The response to intraarterial chemotherapy (IAC) comprising 100 mg/m(2) of cisplatin (CDDP) and 40 mg/m(2) of pirar...

Descripción completa

Detalles Bibliográficos
Autores principales: Koga, Fumitaka, Kitahara, Satoshi, Arai, Kyoko, Honda, Mikihiko, Sumi, Shuhei, Yoshida, Ken‐ichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2000
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926463/
https://www.ncbi.nlm.nih.gov/pubmed/10804290
http://dx.doi.org/10.1111/j.1349-7006.2000.tb00961.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926463/
https://www.ncbi.nlm.nih.gov/pubmed/10804290
http://dx.doi.org/10.1111/j.1349-7006.2000.tb00961.x

Ejemplares similares